Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials

Angela Moore; Suzanne Bruce; Neil Sadick; Eduardo Tschen; Philip Werschler; Sunil Dhawan; Douglas Farsha; Michael Gold; Scott Guenthner; Steve Kempers; Leon Kircik; Jennifer Parish; Marta Rendon; Phoebe Rich; Linda Stein-Gold; Stephen Tyring; Robert Weiss; Adnan Nasir; Carsten Schmitz; Terry Boodhoo; Alexandre Kaoukhov; David Berk; Fran Cook-Bolden; Ayman Grada

doi:10.25251/skin.4.supp.51

Angela Moore
Suzanne Bruce
Neil Sadick
Eduardo Tschen
Philip Werschler
Sunil Dhawan
Douglas Farsha
Michael Gold
Scott Guenthner
Steve Kempers
Leon Kircik
Jennifer Parish
Marta Rendon
Phoebe Rich
Linda Stein-Gold
Stephen Tyring
Robert Weiss
Adnan Nasir
Carsten Schmitz
Terry Boodhoo
Alexandre Kaoukhov
David Berk
Fran Cook-Bolden
Ayman Grada

Keywords

Acne Vulgaris, Acne, Sarecycline

Abstract

Abstract not available.

References

Moore A, Green LJ, Bruce S, SadickN, TschenE, WerschlerP, Cook-Bolden FE, DhawanSS, ForshaD, Gold MH, GuenthnerS. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials. Journal of drugs in dermatology: JDD. 2018 Sep;17(9):987-96.

Poster PDF

Published

Sep 2, 2020

DOI https://doi.org/10.25251/skin.4.supp.51

How to Cite

Moore, A., Bruce, S., Sadick, N., Tschen, E., Werschler, P., Dhawan, S., Farsha, D., Gold, M., Guenthner, S., Kempers, S., Kircik, L., Parish, J., Rendon, M., Rich, P., Stein-Gold, L., Tyring, S., Weiss, R., Nasir, A., Schmitz, C., Boodhoo, T., Kaoukhov, A., Berk, D., Cook-Bolden, F., & Grada, A. (2020). Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-Blind Clinical Trials. SKIN The Journal of Cutaneous Medicine, 4(5), s52. https://doi.org/10.25251/skin.4.supp.51

Issue

Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)

Section

Acne & Rosacea

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by the following user license:

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Author Biography

Alexandre Kaoukhov

Most read articles by the same author(s)

James Del Rosso, Scott Guenthner, Chih-ho Hong, John E Jett, Philip M. Brown, David S. Rubenstein, Stephen Piscitelli, Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Jonathan Silverberg, Leon Kircik, Melinda Gooderham, Gaia Gallo, Eric Wolf, Helena Agell, Fan Emily Yang, Yuxin Ding, Eric Simpson, Patient-Level, Visit-by-Visit Data Highlight the Extent of Skin and Itch Improvement in Atopic Dermatitis With Lebrikizumab , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Leon Kircik, Zoe D Draelos, Eric Guenin, Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Tolerability, and Spreadability , SKIN The Journal of Cutaneous Medicine: Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Daniel Shrager, Scott Guenthner, David Cohen, Haixin Zhang, Daniel Richman, Andrew Korotzer, Shikha Bansal, Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE) , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Benjamin Ehst, George Han, Scott Guenthner, Kimberly Eads, Abby Jacobson, Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies , SKIN The Journal of Cutaneous Medicine: Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas
A Moore, L Green, S Bruce, N Sadick, E Tschen, P Werschler, S Dhawan, D Forsha, M Gold, S Guenthner, S Kempers, L Kircik, J Parish, M Rendon, P Rich, L Stein-Gold, S Tyring, R Weiss, A Nasir, C Schmitz, T Boodhoo, A Kaoukhov, D Berk, F Cook-Bolden, Ayman Grada, Once-Daily Oral Sarecycline 1.5 mg/kg/day is Effective for Moderate to Severe Acne Vulgaris: Results from Two 12-Week, Phase 3, Randomized, Double-blind Clinical Trials , SKIN The Journal of Cutaneous Medicine: Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Catherine Hren, Eduardo Tschen, Terry Jones, et al., Safety of Hydrogen Peroxide Topical Solution, 40% (w/w) in Patients With Skin of Color and Seborrheic Keratoses: Pooled Analysis of Two Phase 3, Randomized, Double- Blind, Vehicle-Controlled, Parallel-Group Studies , SKIN The Journal of Cutaneous Medicine: Vol. 3 No. 2 (2019)
Maulik Manharlal Dhandha, Debjit Ghosh, Stephen Tyring, Peter Rady, Atypical Human Papillomavirus Infection with Secondary Tinea in a Middle-Aged Caucasian Male , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23
Howard Sofen, Stephen Tyring, Sandra Marchese Johnson, Scott Guenthner, Patrick Shannon, Philip M. Brown, Katherine Tillman, Nancy Fitzgerald, Brandon Kirsch, Anna Tallman, Tapinarof Cream 1% Once Daily Improves Patient-reported Outcomes in the Treatment of Mild to Severe Intertriginous Plaque Psoriasis , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 6 (2023): November 2023 Issue
Steven R Feldman, MD, PhD, Tracey C Vlahovic, DPM, Warren S Joseph, DPM, C Ralph Daniel, MD, Boni Elewski, MD, Phoebe Rich, MD, Shari R Lipner, MD, PhD, Monthly Usage of Efinaconazole 10% Solution in Two Phase 3 Randomized Trials: Is One 4-mL Bottle Enough for Proper Treatment? , SKIN The Journal of Cutaneous Medicine: Vol. 7 No. 4 (2023): July Issue & Posters from FCPANP 23

<< < 8 9 10 11 12 13 14 > >>

Main Article Content

Keywords

Abstract

References

Article Sidebar

Article Details

Alexandre Kaoukhov

Similar Articles

Most read articles by the same author(s)